Benitec Biopharma (BNTC) Depreciation & Amortization (CF) (2019 - 2025)
Benitec Biopharma (BNTC) posted Depreciation & Amortization (CF) of $14000.0 for Q4 2025, up 7.69% sequentially from $13000.0 in Q3 2025, and little changed YoY from $14000.0 in Q4 2024.
Powered by 
Analysis
Benitec Biopharma (BNTC) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $14000.0 in Q4 2025.
- Quarterly Depreciation & Amortization (CF) changed 0.0% year-over-year to $14000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54000.0 (down 40.0% YoY) and the FY2025 annual result came in at $66000.0, down 24.14% from the prior year.
- Depreciation & Amortization (CF) grew to $14000.0 in Q4 2025 per BNTC's latest filing, from $13000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $67000.0 in Q1 2021 and troughed at $6000.0 in Q2 2022.
- A 5-year average of $30100.0 and a median of $25000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) tumbled 88.46% in 2022, then soared 250.0% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $55000.0 in 2021, then decreased by 25.45% to $41000.0 in 2022, then sank by 58.54% to $17000.0 in 2023, then retreated by 17.65% to $14000.0 in 2024, then changed by 0.0% to $14000.0 in 2025.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $14000.0, $13000.0, and $14000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Benitec Biopharma | 588.88 Mn | 588.88 Mn | - | 14,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 41,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Mar 31, 2021 | 67,000.00 |